| scholarly article | Q13442814 |
| P50 | author | Gita Ramjee | Q42571276 |
| Jennifer E Balkus | Q87716487 | ||
| Zvavahera M Chirenje | Q87716506 | ||
| Sharon Hillier | Q95149245 | ||
| Salim Abdool Karim | Q18161438 | ||
| P2093 | author name string | Elizabeth R Brown | |
| Anne Coletti | |||
| Lydia Soto-Torres | |||
| Francis Martinson | |||
| Bonus Makanani | |||
| Nyaradzo Mgodi | |||
| Cheri Reid | |||
| P2860 | cites work | Hormonal contraception and the risk of HIV acquisition among women in South Africa | Q43678639 |
| Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. | Q44268615 | ||
| Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1. | Q45752973 | ||
| Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis | Q21144588 | ||
| Contraceptive failure in the United States | Q24630988 | ||
| Hormonal contraceptive methods and risk of HIV acquisition in women: a systematic review of epidemiological evidence | Q27005890 | ||
| Marginal structural models and causal inference in epidemiology | Q29619287 | ||
| Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies | Q30660068 | ||
| Assessing the effect of hormonal contraception on HIV acquisition in observational data: challenges and recommended analytic approaches | Q30671120 | ||
| Injectable and oral contraceptives and risk of HIV acquisition in women: an analysis of data from the MDP301 trial | Q30823365 | ||
| Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling | Q34123283 | ||
| Contraception and health | Q34287368 | ||
| Hormonal contraception and risk of HIV-1 acquisition: results of a 10-year prospective study | Q34314348 | ||
| Hormonal contraception and the risk of HIV acquisition | Q34588016 | ||
| Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women | Q34874237 | ||
| Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study | Q35699938 | ||
| Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study | Q35817142 | ||
| Hormonal contraception and HIV risk: evaluating marginal-structural-model assumptions | Q36001388 | ||
| Constructing inverse probability weights for marginal structural models | Q37321459 | ||
| Highly effective contraception and acquisition of HIV and other sexually transmitted infections | Q37391024 | ||
| The effects of injectable hormonal contraceptives on HIV seroconversion and on sexually transmitted infections | Q37849690 | ||
| Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study | Q37873613 | ||
| Use of hormonal contraceptives and HIV acquisition in women: a systematic review of the epidemiological evidence. | Q38122873 | ||
| Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women | Q38877629 | ||
| Oral and injectable contraception use and risk of HIV acquisition among women in sub-Saharan Africa | Q39232370 | ||
| P2507 | corrigendum / erratum | Corrigendum to "oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial" [contraception 2016; 93 (1): 25-31]. | Q44696519 |
| P433 | issue | 1 | |
| P304 | page(s) | 25-31 | |
| P577 | publication date | 2015-10-28 | |
| P1433 | published in | Contraception | Q2995704 |
| P1476 | title | Oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial | |
| P478 | volume | 93 |
| Q62486620 | Acquisition of Sexually Transmitted Infections among Women Using a Variety of Contraceptive Options: A prospective Study among High-risk African Women |
| Q37409664 | An updated systematic review of epidemiological evidence on hormonal contraceptive methods and HIV acquisition in women |
| Q38850149 | Dapivirine vaginal ring use does not diminish the effectiveness of hormonal contraception |
| Q89438252 | Depot medroxyprogesterone acetate administration alters immune markers for HIV preference and increases susceptibility of peripheral CD4+ T cells to HIV infection |
| Q46749807 | Discordance between Self-Reported Contraceptive Use and Detection of Exogenous Hormones among Malawian Women Enrolling in a Randomized Clinical Trial |
| Q90494354 | Evidence on factors influencing contraceptive use and sexual behavior among women in South Africa: A scoping review |
| Q92526598 | Hormonal contraception and HIV acquisition among women: an updated systematic review |
| Q40515915 | Levonorgestrel in contraceptives and multipurpose prevention technologies: does this progestin increase HIV risk or interact with antiretrovirals? |
| Q89664038 | Norethisterone Enanthate Increases Mouse Susceptibility to Genital Infection with Herpes Simplex Virus Type 2 and HIV Type 1 |
| Q90677566 | Recent levels and trends in HIV incidence rates among adolescent girls and young women in ten high-prevalence African countries: a systematic review and meta-analysis |
| Q44696519 | Corrigendum to "oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial" [contraception 2016; 93 (1): 25-31]. | main subject | P921 |
Search more.